Evidence map›Paper›PMID 41726072›Full record

ArticleMateria socio-medica2025

Assessing Venous Thromboembolism Incidence and Risk Factors: a Narrative Review.

Abdullah D Alotaibi

Abstract read
In one paragraph

Article in Materia socio-medica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdullah D AlotaibiDepartment of Internal Medicine, College of Medicine, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Deep venous thrombosis (DVT) and pulmonary embolism (PE) are the venous thromboembolism (VTE) events that together present a major healthcare problem in the world, which results in significant morbidity, mortality and economic outflow. VTE is a multifactorial disorder, determined by a combination of risk factors including hospitalization, surgery, critical care, and one or more isolated medical conditions. Objective: The objective of the study is to provide a comprehensive assessment of the prevalence of VTE and to identify key risk factors across various clinical and demographic conditions, in order to inform prophylactic measures. Methods: A literature search was conducted on PubMed, Scopus, and Google Scholar among the studies that were published between 1998 and 2022 in the English language. The keywords were used as "venous thromboembolism", "deep vein thrombosis", "pulmonary embolism", "incidence", and "risk factors". The observational, cohort studies, and systematic reviewed research on the VTE epidemiology and risk factors among human populations were considered as the eligible studies. Studies with improper methodologies and editorials, non-English studies were eliminated. Results: The incidence of VTE varies worldwide, ranging from 2 cases per 1,000 person-years, with higher prevalence in hospitalized patients (15-30%) and critically ill patients (up to 20 %). The main risk factors include advanced age, hospitalisation, and surgical intervention, as well as malignant tumours (4-7-fold increased risk), obesity, immobility, inherited thrombophilia with a common genetic background, and rare diseases such as KILT syndrome. Additionally, ethnic and gender differences influence the incidence. Conclusion: VTE is a complex condition that must be prevented on an individual basis, considering different risk profiles. Future research should focus on prospective studies across various groups to enhance risk assessment models and enable personalised thromboprophylaxis, thereby reducing the burden of VTE.

Indexed as

Deep Vein ThrombosisIncidencePrimary PreventionPulmonary EmbolismRisk FactorsVenous Thromboembolism

Identifiers

PMID41726072
PMCPMC12923284

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.